Catalyst Wire Dossier Catalyst Wire Dossier

Ranibizumab Port Delivery System

ranibizumab · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ranibizumab Port Delivery System, covering 2021-05-06 to 2021-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration [Phase 2]

See pricing